The Wistar Institute
Records under this name other than the patents The Wistar Institute holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,669,243 | Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 8,759,367 | Compounds and Methods for the Prevention and Treatment of Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 9,983,215 | Methods and Compositions for Diagnosis of Ectopic Pregnancy Formerly held In force · High confidence | In force | High confidence | |
| US 9,568,486 | Methods and Compositions for Diagnosis of Ectopic Pregnancy Formerly held In force · High confidence | In force | High confidence | |
| US 12,290,561 | Adenoviral vectors encoding hepatitis b viral antigens fused to herpes virus glycoprotein d and methods of using the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,850,282 | Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,514,219 | Method for distinguishing between head and neck squamous cell carcinoma and lung squamous cell carcinoma Term ended Term ended Nov 16, 2026 · USPTO record | Term ended | Term ended Nov 16, 2026 | USPTO record |
| US 8,575,141 | Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer Formerly held Lapsed on the fee record Ended Nov 5, 2025 · High confidence | Lapsed on the fee record | Ended Nov 5, 2025 | High confidence |
| US 8,137,972 | Biocompatible, Biodegradable Polymer-Based, Lighter Than or Light as Water Scaffolds for Tissue Engineering and Methods for Preparation and Use Thereof Formerly held Term ended Term ended Mar 17, 2025 · High confidence | Term ended | Term ended Mar 17, 2025 | High confidence |
| US 7,544,465 | Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activity Term ended Term ended Jul 23, 2024 · USPTO record | Term ended | Term ended Jul 23, 2024 | USPTO record |